Premarket Movers | Vir Biotech Soars 53%; Keysight Technologies Gains 15%; SanDisk Jumps over 2%; Novo Nordisk Falls 3%

Tiger Newspress
02/24

Vir Biotechnology, Inc. stock surgeed 53% in premarket trading after the small biotech company smashed Wall Street's fourth-quarter sales expectations and signed a collaboration deal with Astellas Pharma (ALPMY).

Electronic equipment maker Keysight Technologies forecast second-quarter profit ahead of Wall Street estimates, sending its shares up about 15% in premarket trading.

Storage shares rose in premarket trading. SanDisk up 2.55%; Seagate Tech, Western Digital up around 1%.

Novo Nordisk shares fell another 3% in premarket trading after closing 16% lower on Monday. Novo Nordisk's miss of a key goal in a late-stage comparison clinical trial of obesity drug CagriSema with Eli Lilly's Zepbound is a blow to the Danish drugmaker's long-term outlook, Citi analysts say.

Kratos Defense & Security Solutions reported fourth quarter results that exceeded analyst expectations, but shares fell 4.5% in premarket trading as the defense technology company’s first quarter revenue guidance disappointed investors.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10